To compare the characteristics of optical coherence tomography in eyes with treatment-naïve typical neovascular age-related macular degeneration (typical nAMD), polypoidal choroidal vasculopathy (PCV), and retinal angiomatous proliferation (RAP). Methods: One hundred fifty-three eyes newly diagnosed with exudative AMD were retrospectively collected. All study eyes were classified into three subtypes: typical nAMD, PCV, and RAP. Subfoveal choroidal thickness (SFCT) was measured using enhanced depth imaging optical coherence tomography (EDI-OCT). Central macular thickness (CMT) and other OCT features including intraretinal cystoid fluid and subretinal fluid were also evaluated in all eyes. SFCT, CMT and other OCT features were compared among the three subtypes of exudative AMD. Results: Seventy-four eyes with typical nAMD, 55 eyes with PCV, and 24 eyes with RAP were included. SFCT was significantly thickest in PCV and thinnest in RAP (p < 0.001). RAP showed the thickest CMT and the highest frequency of intraretinal cystoid fluid (p = 0.004, p < 0.001, respectively).
M easurement of subfoveal choroidal thickness. The image was obtained using enhanced-depth imaging optical coherence tomography (OCT). Choroidal thickness (double-head arrow) was defined as the vertical distance drawn from the outer border of the retinal pigment epithelium to the inner border of the sclera using Cirrus High-Definition-OCT software.
Figure 3.
Central macular thickness modification using a built-in segmentation-modifying tool of optical coherence tomography. Segmentation lines for retinal pigment epithelium (red dotted line) are determined automatically for each of the volume scans, and the central macular thickness is provided (A). Using the modifying tool, the cursor line on retinal pigment epithelium is moved to the level of Bruch's membrane. W ith this movement, the modified central macular thickness is determined (B). (Fig. 5) . 
